skip to main content

Chemistry, part 2

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heteropentacyclic compound > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heteropentacyclic compound > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organic heteropolycyclic compound > organic heteropentacyclic compound > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
organooxygen compound > oxacycle > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organonitrogen heterocyclic compound > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > organonitrogen heterocyclic compound > pyranoindolizinoquinoline > (2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid

Preferred term

(2s)-2-/{2-[(1,4'-bipiperidin-1'-ylcarbonyl)oxy]-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl/}-2-hydroxybutanoic acid  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • 0

formula

  • C33H40N4O7

inchi

  • InChI=1S/C33H40N4O7/c1-3-22-23-16-21(44-32(42)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26(25(19-38)30(37)39)33(43,4-2)31(40)41/h8-9,16-17,20,38,43H,3-7,10-15,18-19H2,1-2H3,(H,40,41)/t33-/m0/s1

inchikey

  • DCYPPLWVDXGNOW-XIFFEERXSA-N

mass

  • 604.704

monoisotopicmass

  • 604.28970

smiles

  • O(C(=O)N1CCC(N2CCCCC2)CC1)C3=CC=4C(=C5CN6C(C5=NC4C=C3)=CC([C@@](O)(CC)C(O)=O)=C(C6=O)CO)CC

subset

  • 2_STAR

synonym EXACT

  • (2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoic acid

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:229812

Download this concept:

RDF/XML TURTLE JSON-LD